Leyden Laboratories
Latest round
- Series B
Last raised
- Jan 2022
Total raised
- $187M
Investors
- 7
About Leyden Laboratories
Founded in 2020, and headquartered in Leiden, Netherlands, Leyden Laboratories specializes in developing innovative healthcare solutions focused on infectious diseases, particularly through advanced vaccine candidates aimed at enhancing immunity. It focuses on healthcare innovations targeting infectious diseases and immunology. The company was co-founded by Dinko Valerio, Koenraad Wiedhaup, and Ronald Brus, with Koenraad Wiedhaup serving as CEO.V. Leyden Laboratories specializes in innovative healthcare solutions focused on infectious diseases and immunology. Their core product offerings include advanced vaccine candidates designed to provide robust immunity against various pathogens, leveraging proprietary technology to enhance efficacy and safety profiles.60. The company generates revenue through strategic partnerships and collaborations with stakeholders in the healthcare sector, including government entities and private healthcare providers. Their business model encompasses contractual agreements that facilitate the development and distribution of vaccine products, with revenue stemming from milestone payments and potential royalties upon market entry.
Who invested in Leyden Laboratories
7 investors across 2 rounds
See all investors in Leyden Laboratories
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Leyden Laboratories
Who invested in Leyden Laboratories?
Leyden Laboratories has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leyden Laboratories raised?
Leyden Laboratories has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Leyden Laboratories last raise money?
Leyden Laboratories's most recent round on record is a Series B, in Jan 2022.
What does Leyden Laboratories do?
Founded in 2020, and headquartered in Leiden, Netherlands, Leyden Laboratories specializes in developing innovative healthcare solutions focused on infectious diseases, particularly through advanced vaccine candidates aimed at enhancing immunity.
Where is Leyden Laboratories headquartered?
Leyden Laboratories is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Leyden Laboratories?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Leyden Laboratories's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Leyden Laboratories? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.